References
- Chen J, Sadakata M, Ishida M, et al. Baby massage ameliorates neonatal jaundice in full-term newborn infants. Tohoku J Exp Med. 2011;223(2):97–102.
- Faal G, Khatib Masjedi H, Sharifzadeh G, et al. Efficacy of zinc sulfate on indirect hyperbilirubinemia in premature infants admitted to neonatal intensive care unit: a double-blind, randomized clinical trial. BMC Pediatr. 2020;20(1):1–7.
- Dani C, Poggi C, Pratesi S. Bilirubin and oxidative stress in term and preterm infants. Free Radic Res. 2019;53(1):2–7.
- Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Seminars in Neonatology.2002;7(2):111–119.
- Kliegman RM, Stanton BF, III JWSG, Schor NF, et al. Nelson textbook of pediatrics. 21st ed. Philadelphia (PA): Elsevier; 2020. 4121.
- Hassan AM, Abdulrahman A, Husain RH. Effect of ursodeoxycholic acid in lowering neonatal indirect hyperbilirubinemia: a randomized controlled trial. Merit Res J Med Med Sci. 2015;3(9):402–405.
- Chawla D, Parmar V. Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta-analysis. Indian Pediatr. 2010;47(5):401–407.
- Ughasoro MD, Adimorah GN, Chukwudi NK, et al. Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy. CEG. 2019;12:349–354.
- Shahramian I, Tabrizian K, Ostadrahimi P, et al. Therapeutic effects of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a randomized double-blind clinical trial. Arch Anesthesiol Crit Care. 2019;5(3):99–103.
- El-Gendy F, Bahbah W, Al Kafory E. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. Menoufia Med J. 2019;32(3):1059–1063.
- Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36(3):525–531.
- Kim DJ, Yoon S, Ji SC, et al. Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction. Sci Rep. 2018;8(1):11874.
- Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997;24(5):573–589.
- Honar N, Ghashghaei Saadi E, Saki F, et al. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. J Pediatr Gastroenterol Nutr. 2016;62(1):97–100.
- Schulz KF, Altman DG, Moher D, Group C. Updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726–732.
- Lissauer T, Fanaroff AA, Miall L, et al. Neonatology at a glance. 19th ed. John Wiley & Sons; 2020.
- Sealed Envelope Ltd. Create a blocked randomisation list. 2016 [Accessed 2016 Aug 24]. Available from: https://www.sealedenvelope.com/simple-randomiser/v1/lists.
- AAP Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics. 2001;108(3):763–765.
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316.
- Cuperus FJ, Hafkamp AM, Havinga R, et al. Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats. Gastroenterology. 2009; 136(2):673.e1–682.e1.